This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
3 MedTech Innovators Shaping Healthcare in 2026: AVAH, INGN & CCLD
by Indrajit Bandyopadhyay
AVAH, INGN & CCLD show how home care, portable oxygen tech and cloud healthcare IT are reshaping care delivery and efficiency into 2026.
medical medical-devices
ECL Boosts High-Tech Water Platform With Ovivo's Electronics Business
by Zacks Equity Research
Ecolab closes Ovivo Electronics acquisition, expanding high-tech water solutions for semiconductors and boosting circular water offerings.
medical medical-devices
Top China Tech Plays in US Markets Amid Trade Deal Progress
by Vasundhara Sawalka
Chinese technology stocks in U.S. markets are rebounding as trade deal progress lifts sentiment and major advances in chips, EVs and AI boost confidence.
artificial-intelligence china e-commerce electric-vehicles medical-devices robotics tech-stocks
3 Skyrocketing MedTech Stocks That Might Lose Steam in 2026
by Zacks Equity Research
Here are some surging MedTech stocks - GMED, TMDX and HIMS - that may face slowing momentum in 2026.
medical medical-devices
Here's Why You Should Hold DaVita Stock in Your Portfolio for Now
by Zacks Equity Research
DVA stock gets support from a patient-centric model, Q3 revenue growth and overseas expansion, even as reliance on commercial payers remains a risk.
medical medical-devices
Should You Continue to Hold CRL Stock in Your Portfolio for Now?
by Zacks Equity Research
Charles River gains from strong RMS demand, strategic partnerships and solid finances but faces macro and competitive pressures in 2025.
medical medical-devices
Boston Scientific's Global Expansion: What's Behind the Growth?
by Moumi Mondal
BSX expands globally with R&D, AI-driven manufacturing and Emerging Markets, aiming for $1B+ revenues in China in 2025.
medical medical-devices
Here's Why You Should Retain CLOV Stock in Your Portfolio Now
by Zacks Equity Research
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
medical medical-devices
Will Direct Distribution in Southern Europe Boost ISRG's Margins?
by Indrajit Bandyopadhyay
ISRG plans a 2026 shift to direct distribution in Italy, Spain, and Portugal, aiming to lift margins by capturing distributor economics with execution risk.
medical medical-devices
GEHC Expands Healthcare Access Through Indonesia MoH Partnership Deal
by Zacks Equity Research
GE HealthCare partners with Indonesia's Health Ministry under SIHREN to deploy CT scanners nationwide, expanding diagnostics across public hospitals.
medical medical-devices